在体内有效的mRNA输送的帕西克洛芬基离子化脂质
Shiqi Wu1, Kexin Su1, Xinxin Yan1
1College of Pharmaceutical Sciences, Liangzhu Laboratory, Eye Center of the Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou 310058, China.
概括
研究人员开发了基于帕西克洛芬的新型电离性脂质 (PILs) 用于脂质纳米粒子 (LNP) 传递mRNA疗法. 这些PIL-LNP显示在体外和体内增强的mRNA输送,优于针对性疗法和疫苗的现有LNP配方.
科学领域:
- 生物技术是生物技术.
- 药物输送系统 药物输送系统
- 分子医学是分子医学.
背景情况:
- 使者RNA (mRNA) 疗法利用脂质纳米粒子 (LNP) 传递来治疗各种疾病.
- 可电离的阴离子脂对于LNP配方至关重要,氨基核显著影响输送效率.
- 优化LNP性能需要重新设计脂胺核以改善mRNA传递.
研究的目的:
- 理性地设计和合成一个基于偏旋的电离性脂质 (PILs) 的库.
- 为了评估基于PIL的LNP在mRNA输送中的有效性,在体外和体内.
- 为了比较优化的 PIL-LNP 与已建立的 LNP 配方的性能.
主要方法:
- 合成了198种基于帕西克洛芬的电离性脂质 (PIL).
- 将PILs制成脂质纳米颗粒 (LNP) 用于mRNA输送.
- 在体外和体内对LNP特征,mRNA输送和治疗疗效的评估.
主要成果:
- PIL-LNP表现出最佳的颗粒大小,泽塔潜力,mRNA结合,内分体逃逸和体外输送.
- 量身定制的PIL结构在肝脏或体内多器官表达中促进了向的mRNA表达.
- 与FDA批准的DLin-MC3-DMA LNP和COVID-19疫苗LNP (SM-102,ALC-0315) 相比,优化的PIL-LNP显示出更高的疗效.
结论:
- 基于偏旋的电离性脂质代表了推动mRNA治疗的有希望的平台.
- PIL-LNP为开发有效的向肝脏的mRNA药物和疫苗提供了潜力.
- 这项研究强调了可电离性脂质结构对mRNA传递性能的影响.
相关概念视频
Regulated mRNA Transport
6.2K
In eukaryotes, transcription and translation are compartmentalized; an mRNA is first synthesized in the nucleus and then selectively transported to the cytoplasm for protein synthesis. Before transport, a pre-mRNA undergoes several steps of post-transcriptional modifications including splicing, 5' capping, and the addition of a poly-adenine tail. Various proteins bind to the pre-mRNA during these modifications. The mRNA transport takes place with the help of multiple proteins playing...
6.2K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K


